SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,887,600 | +98096.7% | 130,000 | +18.2% | 0.83% | -16.4% |
| Q1 2023 | $15,161 | -41.5% | 110,000 | -45.0% | 1.00% | -42.4% |
| Q4 2022 | $25,916 | -99.9% | 200,000 | 0.0% | 1.73% | +12.2% |
| Q3 2022 | $22,108,000 | +323.8% | 200,000 | +185.7% | 1.54% | +1231.9% |
| Q1 2021 | $5,217,000 | -56.3% | 70,000 | 0.0% | 0.12% | -59.2% |
| Q4 2020 | $11,934,000 | -0.0% | 70,000 | -17.6% | 0.28% | -38.1% |
| Q3 2020 | $11,937,000 | -32.3% | 85,000 | -22.7% | 0.46% | -31.8% |
| Q2 2020 | $17,637,000 | +20.2% | 110,000 | -26.7% | 0.67% | -1.3% |
| Q1 2020 | $14,673,000 | -54.5% | 150,000 | -40.0% | 0.68% | -47.0% |
| Q4 2019 | $32,260,000 | +93.2% | 250,000 | +12.8% | 1.29% | +26.7% |
| Q3 2019 | $16,698,000 | -51.2% | 221,700 | -1.5% | 1.02% | -48.3% |
| Q2 2019 | $34,189,000 | -4.4% | 225,000 | -25.0% | 1.96% | -18.7% |
| Q1 2019 | $35,757,000 | +264.1% | 300,000 | +233.3% | 2.42% | +203.3% |
| Q4 2018 | $9,822,000 | – | 90,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |